erlotinib hydrochloride has been researched along with Nevi, Melanocytic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ermolovich, T; Hemperly, S; Lountzis, NI; Purcell, SM; Sheikh, HA | 1 |
1 other study(ies) available for erlotinib hydrochloride and Nevi, Melanocytic
| Article | Year |
|---|---|
Darkening and eruptive nevi during treatment with erlotinib.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Melanoma; Nevus, Pigmented; Protein Kinase Inhibitors; Skin Neoplasms | 2019 |